Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Meeting highlights from the Paediatric Committee: 24 - 26 June 2009 1 juli 2009Press releaseHumanPaediatrics Committee for Advanced Therapies adopts first classification recommendation for an advanced therapy medicinal product 30 juni 2009Press releaseHumanAdvanced therapiesInnovation Public statement on the recommendation to lift the suspension of the marketing authorisation for Optison (perflutren) 29 juni 2009News European Medicines Agency update on safety of insulin glargine 29 juni 2009Press releaseMedicines Meeting highlights from the Committee for Medicinal Products for Human Use,22-25 June 2009 26 juni 2009Press releaseHuman European Medicines Agency recommends first marketing authorisation for an advanced therapy medicinal product 26 juni 2009Press releaseHumanAdvanced therapiesMedicines Supply shortages of Cerezyme and Fabrazyme - priority access for patients most in need of treatment recommended 25 juni 2009Press release European Medicines Agency recommends withdrawal of dextropropoxyphene-containing medicines 25 juni 2009Press releaseHumanMedicines Menarini International Operations Luxembourg withdraws its marketing authorisation application for Factive (gemifloxacin) 23 juni 2009Press release Committee for medicinal products for veterinary use: Meeting of 16-18 June 2009 19 juni 2009Press releaseVeterinary 1 … 297 298 299 300 301 Page 301 of 380 302 303 304 305 … 380
Meeting highlights from the Paediatric Committee: 24 - 26 June 2009 1 juli 2009Press releaseHumanPaediatrics
Committee for Advanced Therapies adopts first classification recommendation for an advanced therapy medicinal product 30 juni 2009Press releaseHumanAdvanced therapiesInnovation
Public statement on the recommendation to lift the suspension of the marketing authorisation for Optison (perflutren) 29 juni 2009News
Meeting highlights from the Committee for Medicinal Products for Human Use,22-25 June 2009 26 juni 2009Press releaseHuman
European Medicines Agency recommends first marketing authorisation for an advanced therapy medicinal product 26 juni 2009Press releaseHumanAdvanced therapiesMedicines
Supply shortages of Cerezyme and Fabrazyme - priority access for patients most in need of treatment recommended 25 juni 2009Press release
European Medicines Agency recommends withdrawal of dextropropoxyphene-containing medicines 25 juni 2009Press releaseHumanMedicines
Menarini International Operations Luxembourg withdraws its marketing authorisation application for Factive (gemifloxacin) 23 juni 2009Press release
Committee for medicinal products for veterinary use: Meeting of 16-18 June 2009 19 juni 2009Press releaseVeterinary